Male pattern baldness and its management: an update.
Paul C. Cotterill, Walter Unger
Abstract
Paul C. Cotterill, Walter Unger
Abstract
Androgenetic alopecia (AGA) sometimes referred to as `male pattern baldness' (MPB) may affect up to 50% of males between the ages of 30 and 50 years. The authors of this article review the medical and surgical approaches currently available to treat AGA. Medications, such as topical minoxidil, which are currently being marketed as a treatment for AGA, as well as other drugs currently under investigation are examined. Recent advances in punch hair transplantation, alopecia reductions, and flap surgery are also discussed.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Androgenetic alopecia (AGA) sometimes referred to as `male pattern baldness' (MPB) may affect up to 50% of males between the ages of 30 and 50 years. The authors of this article review the medical and surgical approaches currently available to treat AGA. Medications, such as topical minoxidil, which are currently being marketed as a treatment for AGA, as well as other drugs currently under investigation are examined. Recent advances in punch hair transplantation, alopecia reductions, and flap surgery are also discussed.
Key concepts: Male-pattern baldness, Hair transplantation, Medicine, Minoxidil, Dermatology, Hair loss, Surgery, Scalp